Spots Global Cancer Trial Database for A Phase II Trial of Intermediate Radiation Dose For Lymphoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase II Trial of Intermediate Radiation Dose For Lymphoma
Official Title: A Phase II Trial of Intermediate Radiation Dose For Low Grade Follicular Lymphoma
Study ID: NCT05284825
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine the optimal radiation dose fractionation regimen for low grade follicular lymphoma. It is hypothesized that the complete response rate with the use of 12 Gy in 6 daily fractions is 80% (10% total width of the confidence interval) at 3 months. This phase II study will evaluate whether an intermediate dose for follicular lymphoma is associated with excellent response rates while minimizing acute and late toxicity.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Contact Details
Name: May Tsao, MD
Affiliation: Sunnybrook Health Sciences Centre
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
